Glaukos GKOS Business Segments
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Revenue by Product | ||||||
| Corneal Health | $21.31M+15.0% | $23.97M+12.2% | $23.29M+12.8% | $20.59M+3.9% | $18.53M+0.7% | |
| Glaucoma | $129.26M+46.7% | $119.15M+41.6% | $110.25M+45.0% | $103.53M+36.4% | $88.14M+31.1% | |
| Revenue by Geography | ||||||
| Non Us | $38.23M+21.0% | $35.12M+17.3% | $32.09M+20.4% | $33.6M+16.4% | $31.59M+13.1% | |
| US | $112.34M+49.7% | $108M+42.9% | $101.45M+44.9% | $90.52M+35.5% | $75.07M+30.1% | |
| PP&E (Net) by Geography | ||||||
| Non Us | $273K+60.6% | $199K+41.1% | $191K— | $182K— | $170K— | |
| US | $112.16M+16.1% | $113.05M+15.7% | $110.75M— | $111.63M— | $96.64M— | |
| Capital Expenditure by Geography | ||||||
| Non Us | $123K+273% | $25K— | $24K— | $17K+467% | $33K+267% | |
| US | $3.84M+101% | $2.89M+69.4% | $1.61M+13.6% | $1.16M-45.9% | $1.91M+98.7% | |
| D&A by Geography | ||||||
| Non Us | $11K-8.3% | $12K+33.3% | $13K+30.0% | $13K+62.5% | $12K+50.0% | |
| US | $11.79M+43.5% | $12.15M+39.2% | $9.12M+1.5% | $8.56M-4.8% | $8.22M-7.7% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Glaukos break its business down?
- Glaukos (GKOS) reports revenue by product across 2 parts — Corneal Health and Glaucoma. Each is extracted from the segment footnotes and tracked over time.
- Where does Glaukos's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Glaukos's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
